NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355,608 | +3.5% | 18,502 | +36.8% | 0.00% | 0.0% |
| Q2 2023 | $343,703 | -93.7% | 13,521 | -71.0% | 0.00% | -87.5% |
| Q3 2021 | $5,433,000 | -29.5% | 46,680 | +0.4% | 0.01% | -33.3% |
| Q2 2021 | $7,711,000 | +58.3% | 46,507 | +33.2% | 0.01% | +50.0% |
| Q1 2021 | $4,872,000 | -59.2% | 34,922 | -49.4% | 0.01% | -61.9% |
| Q4 2020 | $11,945,000 | +60.5% | 69,008 | +29.2% | 0.02% | +40.0% |
| Q3 2020 | $7,441,000 | +260.9% | 53,422 | +209.5% | 0.02% | +275.0% |
| Q2 2020 | $2,062,000 | – | 17,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |